Mave Health, a neurotech company, has raised $2.1 million in seed funding led by Blume Ventures with participation from Stanford Angels and other investors to launch a non-invasive wearable headset designed to improve focus, elevate mood, and regulate stress in 20 minutes a day.
The device uses transcranial direct current stimulation (tDCS) – a technology studied for over 25 years with more than 10,000 published papers – to deliver low-intensity electrical stimulation targeting the prefrontal cortex, the brain region associated with attention, emotional regulation, and stress response. Mave recently completed a 500-person beta, with self-reported data after four weeks showing 80% of users reporting productivity gains exceeding 60%, average mood improvement of 77%, and 75% reporting stress reductions above 50%.
“The brain is the most complex system we rely on every day, and modern life is constantly overloading it,” said co-founder and CEO Dhawal Jain. “Instead of chasing short-term boosts that come with long-term costs, we believe in strengthening the underlying systems that drive focus, mood, and stress regulation.”
The headset weighs 100 grams, lasts up to one month on a single charge, and does not collect brain data. A companion app allows users to log sessions and track progress, with integration for fitness wearables.
